Skip to main content

Table 3 Radiopharmaceutical biodistribution at 48 hr after injection

From: 188Re radiopharmaceuticals for radiosynovectomy: evaluation and comparison of tin colloid, hydroxyapatite and tin-ferric hydroxide macroaggregates

 

Activity per gram of organ

Organ

188Re-Sn

188Re-Sn-FHMA

188Re-HA

Thyroid

9,58E-04

6,03E-04

3,31E-04

Lungs

9,18E-04

1,55E-03

8,68E-05

Kidneys

4,39E-04

2,64E-02

3,07E-03

Liver

1,62E-03

2,46E-03

1,68E-04

Spleen

1,53E-04

3,43E-03

9,33E-05

Stomach

3,64E-04

1,98E-04

3,52E-05

Muscle

5,64E-05

2,27E-04

1,62E-04

Bone

3,98E-03

2,62E-04

1,15E-04

Intestines

3,20E-03

3,54E-03

5,76E-04

Heart

3,39E-04

3,17E-04

4,83E-05

Blood

2,67E-04

9,75E-04

2,43E-04

Urine

2,34E-03

1,16E-02

6,52E-03

Urinary bladder

2,56E-03

4,66E-04

1,64E-03

Gall bladder

6,25E-03

5,36E-03

2,08E-04

Joint (knee)

1,01E+00

9,99E-01

6,21E-01

  1. All activities were corrected to the sacrifice time